⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for l19

Every month we try and update this database with for l19 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Radioimmunotherapy With 131I-L19SIP in Patients With CancerNCT01242943
Patients With C...
131I-L19SIP Rad...
18 Years - 75 YearsPhilogen S.p.A.
L19TNFα in Patients With Advanced Solid TumorsNCT01253837
Solid Tumors
Colorectal Canc...
L19TNFa
18 Years - Philogen S.p.A.
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic MelanomaNCT02076646
Metastatic Mela...
L19IL2 - Ph I
L19IL2 at RD - ...
DTIC
18 Years - 70 YearsPhilogen S.p.A.
131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)NCT01124812
Non Small Cell ...
131I-L19SIP Rad...
18 Years - Philogen S.p.A.
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic MelanomaNCT02076646
Metastatic Mela...
L19IL2 - Ph I
L19IL2 at RD - ...
DTIC
18 Years - 70 YearsPhilogen S.p.A.
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid TumoursNCT01058538
Advanced Solid ...
L19IL2
18 Years - Philogen S.p.A.
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid TumoursNCT01058538
Advanced Solid ...
L19IL2
18 Years - Philogen S.p.A.
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer PatientsNCT01198522
Pancreatic Canc...
L19IL2 monoclon...
18 Years - 70 YearsPhilogen S.p.A.
131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid TumorsNCT01125085
Brain Metastase...
131I-L19SIP Rad...
18 Years - Philogen S.p.A.
L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid TumoursNCT02076620
Advanced Solid ...
Sarcoma, Breast...
L19TNFα
Doxorubicin
18 Years - Philogen S.p.A.
Radioimmunotherapy With 131I-L19SIP in Patients With CancerNCT01242943
Patients With C...
131I-L19SIP Rad...
18 Years - 75 YearsPhilogen S.p.A.
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer PatientsNCT01198522
Pancreatic Canc...
L19IL2 monoclon...
18 Years - 70 YearsPhilogen S.p.A.
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid TumoursNCT01058538
Advanced Solid ...
L19IL2
18 Years - Philogen S.p.A.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: